Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome

Kevin Whelan*, Margaret Alexander, Claire Gaiani, Genelle Lunken, Andrew Holmes, Heidi M. Staudacher, Stephan Theis, Maria L. Marco*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Diet is a major determinant of the gastrointestinal microbiome composition and function, yet our understanding of how it impacts the efficacy of prebiotics and probiotics is limited. Here we examine current evidence of dietary influence on prebiotic and probiotic efficacy in human studies, including potential mechanisms. We propose that habitual diet be included as a variable in prebiotic and probiotic intervention studies. This recommendation is based on the potential mechanisms via which diet can affect study outcomes, either directly or through the gut microbiome. We consider the challenges and opportunities of dietary assessment in this context. Lastly, we provide recommendations for the design, conduct and reporting of human clinical trials of prebiotics and probiotics (and other biotic interventions) to account for any effect of diet and nutrition.

Original languageEnglish
Pages (from-to)2785-2794
Number of pages10
JournalNature Microbiology
Volume9
Issue number11
DOIs
Publication statusAccepted/In press - 12 Sept 2024

Fingerprint

Dive into the research topics of 'Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome'. Together they form a unique fingerprint.

Cite this